Baylor College of Medicine, Section of Gastroenterology and Hepatology, Houston, Texas

Dr. Finger is the Eunice L. Dwan Endowed Chair for Diabetes Research and Professor of Surgery at the University of Minnesota, where his research focuses on organ and tissue preservation. In addition, he is a multi-organ abdominal transplant surgeon with a particular focus on kidney and pancreas transplantation. He received a B.S. in Chemical Engineering from UC Davis, an M.D. from Harvard Medical School and Massachusetts Institute of Technology, a Ph.D.

Dr. Griesemer is an Associate Professor of Surgery and Surgical Director of Living Donor and Pediatric Liver Transplant at NYU Langone. His NIH-funded lab studies xenotransplantation in nonhuman primates, human decedents, and living recipients of xenografts.

A Pennsylvania native, Dr. Vahora is proud to return to his alma mater, The George Washington University, where he currently serves as the Medical Director of Liver Transplantation. He completed his internal medicine residency at Case Western Reserve University's MetroHealth Medical Center, followed by a hepatology fellowship at AdventHealth Transplant Institute (formerly Florida Hospital Transplant Institute) and a gastroenterology fellowship at East Carolina University / Vidant Medical Center.<br><br>Dr.

Transplant Hepatologist at Singapore General Hospital<br>Director, Digital Health Transformation, SingHealth Duke-NUS Transplant Centre (SDTC).

Karen Krok is a Professor of Medicine and a hepatologist at the Penn State Milton S. Hershey Medical Center. She serves as Vice Chair of Clinical Affairs for the Department of Medicine. She is also passionate about education and is an Associate Program Director for the Gastroenterology Fellowship.

Parissa Tabrizian, MD, MSc, FACS is a board-certified surgeon, associate professor of surgery who specializes in hepatobiliary and liver transplantation at the Recanati/Miller Transplantation Institute. Dr. Tabrizian earned her medical degree at the University of Vienna medical school and completed her general surgery residency at the Mount Sinai Medical Center in New York. She completed fellowships in surgical oncology and multiorgan transplant surgery at Mount Sinai Hospital. In 2015, Dr.

Dr. Ajmera is a current investigator in the UCSD Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Research Unit where he collaborates with a multidisciplinary team of experts on research in non-invasive biomarkers and patient factors associated with disease severity and prognosis. He is a recipient of an American Association for the Study of Liver Diseases (AASLD) Clinical and Translational Research Award and an NIDDK K23 Career Development Award for his work on the non-invasive assessment of patients with MASLD.

Dr. Lim is a Professor of Medicine and Vice-Chief of the Section of Digestive Diseases at Yale University School of Medicine where he serves as Director of Clinical Hepatology and Associate Medical Chief of YNHHS Digestive Health. He has served the AASLD in several roles, including the HBV SIG steering committee, Viral Hepatitis Elimination Taskforce, AASLD-IDSA HCV guidance panel, and AASLD-IDSA HBV guideline panel.

I received my MD at Russian University of Friendship, Moscow. I then studied biochemistry and immunology during my graduate studies at Christian-Albrecht University, Germany. As a postdoctoral fellow at Columbia University (USA), I studied signal transduction, and expanded my skills in transgenic mouse technologies. I joined UCSD as a principal investigator. The major interest of my research is the identification of new targets for the therapy of MASH and MetALD-associated liver fibrosis and cholestatic fibrosis.